|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
1.26/5.19
|
Enterprise Value
16.68B
|
Balance Sheet |
Book Value Per Share
63.59
|
Cash Flow |
Cash Flow Yield
0.01
|
Income Statement |
Total Revenue
2.75B
|
Operating Revenue Per Share
22.66
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/06/03 02:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includesimmunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software. |